Trial Profile
Pharmacokinetics of Piperacillin and Tazobactam in Anuric Septic Patients Treated by Continuous Veno Venous Hemodiafiltration
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Oct 2013
Price :
$35
*
At a glance
- Drugs Piperacillin/tazobactam (Primary)
- Indications Bacterial infections; Sepsis; Septic shock
- Focus Pharmacokinetics
- Acronyms PTCRRT
- 01 Aug 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Mar 2010 Planned end date changed from 1 Jul 2010 to 1 Aug 2012 as reported by ClinicalTrials.gov.
- 23 Jul 2008 New trial record.